SUBSCRIBE
SUBSCRIBE

89bio

555 Montgomery Street, Suite 1500
San Francisco, CA 94111
Tel: (415) 432-9270
Visit website
Email Us
NEWS
Drug Development
Clinical Catch-Up: August 2-6
It was a busy week for clinical trial announcements. Take a look.
August 6, 2021
 · 
7 min read
 · 
Mark Terry
Load More
JOBS
IN THE PRESS
Press Releases
Roche purchases shares in tender offer for 89bio, Inc
October 30, 2025
 · 
7 min read
Press Releases
Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash
October 2, 2025
 · 
8 min read
Press Releases
89bio, Inc. Announces Agreement to be Acquired by Roche
September 18, 2025
 · 
9 min read
Press Releases
Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH
September 18, 2025
 · 
13 min read
Press Releases
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 5, 2025
September 8, 2025
 · 
1 min read
Press Releases
89bio to Participate in Upcoming September 2025 Investor Conferences
August 29, 2025
 · 
1 min read
Press Releases
89bio Reports Second Quarter 2025 Financial Results and Corporate Updates
August 8, 2025
 · 
8 min read
Press Releases
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 4, 2025
August 5, 2025
 · 
1 min read
Press Releases
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 9, 2025
July 10, 2025
 · 
1 min read
Press Releases
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 6, 2025
June 9, 2025
 · 
1 min read
Load More